News

Pharmabiz7h
Icon Group and Varian expand partnership to deliver advanced cancer technology across the United Kingdom
Icon Group and Varian expand partnership to deliver advanced cancer technology across the United Kingdom: London Saturday, June 28, 2025, 16:00 Hrs [IST] Icon Group, a global lead ...
Pharmabiz6h
Applied StemCell releases hiEX Research iPSC Exosomes to explore next-generation regenerative medicine research
Applied StemCell releases hiEX Research iPSC Exosomes to explore next-generation regenerative medicine research: Milpitas, California Saturday, June 28, 2025, 17:00 Hrs [IST] Appl ...
Pharmabiz8h
Biodexa Pharma activates first clinical study site for phase 3 Serenta trial in familial adenomatous polyposis
Biodexa Pharma activates first clinical study site for phase 3 Serenta trial in familial adenomatous polyposis: United Kingdom Saturday, June 28, 2025, 15:00 Hrs [IST] Biodexa Pha ...
Pharmabiz14h
European Commission approves Eylea 8 mg with extended 6-month treatment interval for nAMD and visual impairment due to DME
European Commission approves Eylea 8 mg with extended 6-month treatment interval for nAMD and visual impairment due to DME: Berlin Saturday, June 28, 2025, 09:00 Hrs [IST] The Eur ...
Pharmabiz9h
KalVista Pharma inks licensing agreement with Pendopharm to commercialize sebetralstat for HAE in Canada
KalVista Pharma inks licensing agreement with Pendopharm to commercialize sebetralstat for HAE in Canada: Cambridge, Massachusetts Saturday, June 28, 2025, 14:00 Hrs [IST] KalVist ...
Pharmabiz12h
WHO issues alert on the use of semaglutide medicines and risk of non-arteritic anterior ischemic optic neuropathy
WHO issues alert on the use of semaglutide medicines and risk of non-arteritic anterior ischemic optic neuropathy: Geneva Saturday, June 28, 2025, 11:00 Hrs [IST] WHO is alerting ...
Pharmabiz10h
US FDA approves label updates for Bristol Myers’ CAR T cell therapies, Breyanzi for LBCL & lymphomas and Abecma for multiple myeloma
US FDA approves label updates for Bristol Myers’ CAR T cell therapies, Breyanzi for LBCL & lymphomas and Abecma for multiple myeloma: Princeton, New Jersey Saturday, June 28, 20 ...
Pharmabiz11h
Bavarian Nordic initiates clinical trials of mpox vaccine in infants and pregnant women
Bavarian Nordic initiates clinical trials of mpox vaccine in infants and pregnant women: Copenhagen, Denmark Saturday, June 28, 2025, 12:00 Hrs [IST] Bavarian Nordic A/S, a global ...
Pharmabiz15h
Centre makes application for WHO GMP & COPP mandatory through ONLDS portal from July 15
Centre makes application for WHO GMP & COPP mandatory through ONLDS portal from July 15: Gireesh Babu, New Delhi Saturday, June 28, 2025, 08:00 Hrs [IST] The Central drug regulato ...
Pharmabiz15h
India’s digital health propels new era of integration and innovation
India’s digital health propels new era of integration and innovation: Nandita Vijayasimha, Bengaluru Saturday, June 28, 2025, 08:00 Hrs [IST] India’s digital health ecosystem ...
Pharmabiz15h
Indian pharma speeds up access to global therapies while targeting treatment gaps
Indian pharma speeds up access to global therapies while targeting treatment gaps: Nandita Vijayasimha, Bengaluru Saturday, June 28, 2025, 08:00 Hrs [IST] Indian pharma is now agg ...
Pharmabiz15h
Experts discuss solutions in enhancing API manufacturing quality at USP Convention 2025
Experts discuss solutions in enhancing API manufacturing quality at USP Convention 2025: Shardul Nautiyal, Mumbai Saturday, June 28, 2025, 08:00 Hrs [IST] Experts discussed soluti ...